

HY-172097 · 50 mg
MedChemExpress · Cat: HY-172097
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/hl22.htmlDescription
HL22 is a harmaline derivative. HL22 significantly inhibits HCT116, MGC803 and MCF7 cancer cell lines, and inhibits MGC803 cell migration and monoclonal formation. The anti-cancer mechanism of HL22 is related to a variety of metabolic pathways and can be used in the study of cancer.